Episode 11 of the Oncology Hour Podcast features a conversation with John Hallick on Lung cancer, MET mutations, and why patients should be aware of biomarker testing and clinical trial options. John Hallick is a lung cancer survivor and founder of the MET Crusaders, who are a community of lung cancer patients, care givers, advocates, researchers, and physicians dedicated to helping patients with the MET alteration live normal lives.

Episode 11 of the Oncology Hour Podcast features a conversation with John Hallick on Lung cancer, MET mutations, and why patients should be aware of biomarker testing and clinical trial options. John Hallick is a lung cancer survivor and founder of the MET Crusaders, who are a community of lung cancer patients, care givers, advocates, researchers, and physicians dedicated to helping patients with the MET alteration live normal lives.

Lung Cancer and MET Mutations

Oncology Hour is a live podcast series that addresses common questions and topics in the cancer community such as cancer treatment options, clinical trials, overview of cancer types, and more featuring Massive Bio team members and Oncology experts. Oncology Hour is hosted by Massive Bio, whose mission is to provide all people with equal access to leading edge therapies and new-emerging clinical trials, regardless of where they live or their ability to pay. Massive Bio is a central hub that connects patients to the best treatments and clinical trials available. Massive Bio's team and technology work together to provide a space dedicated to connecting each patient with the best treatment for them.

Medicine

Alternative Health

Health & Fitness

Oncology Hour is a live podcast series that addresses common questions and topics in the cancer community such as cancer treatment options, clinical trials, overview of cancer types, and more featuring Massive Bio team members and Oncology experts. Oncology Hour is hosted by Massive Bio, whose mission is to provide all people with equal access to leading edge therapies and new-emerging clinical trials, regardless of where they live or their ability to pay. Massive Bio is a central hub that connects patients to the best treatments and clinical trials available. Massive Bio's team and technology work together to provide a space dedicated to connecting each patient with the best treatment for them.

Share Lung Cancer and MET Mutations

Sign up to save your podcasts

Lung Cancer and MET Mutations

Lung Cancer and MET Mutations